72
Participants
Start Date
August 26, 2020
Primary Completion Date
March 15, 2022
Study Completion Date
October 13, 2022
Placebo
Administered IV
LY3041658
Administered IV
Holdsworth House Medical Practice, Sydney
Westmead Hospital, Northmead
Sunshine Coast University Hospital, Birtinya
Fremantle Dermatology, Fremantle
Duke University Medical Center, Durham
Marietta Dermatology Clinical Research, Marietta
Advanced Medical Research, Sandy Springs
Skin Care Research, Inc, Hollywood
Nova Clinical Research, LLC, Miami
University Hospitals Case Medical Center, Cleveland
UC Physicians Office Dermatology, Cincinnati
Washington University School of Medicine, St Louis
Northwest Arkansas Clinical Trials Center, Rogers
Dermatology Research Associates, Los Angeles
First OC Dermatology, Fountain Valley
ForCare Clinical Research, Tampa
Allcutis Research, Inc., Beverly
Beth Israel Deaconess Medical Center, Boston
ALLCUTIS Research, Portsmouth
The Royal Melbourne Hospital, Parkville
Eli Lilly and Company
INDUSTRY